Kimberly-Clark Corp (KMB)

$99.78 -0.87 (-0.86%)
Market Cap 33.41B
Revenue (ttm) 20.06B
Net Income (ttm) 2.55B
EPS (ttm) N/A
PE Ratio 14.04
Forward PE 16.50
Profit Margin 12.69%
Debt to Equity Ratio 4.98
Volume 4,803,300
Avg Vol 6,183,212
Day's Range N/A - N/A
Shares Out 331.89M
Stochastic %K 4%
Beta 0.25
Analysts Sell
Price Target $124.31

Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates through three segments: North America, International Personal Care, and International Family Care and Professional. The company North America segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towe...

Industry: Household & Personal Products
Sector: Consumer Defensive
Phone: 972 281 1200
Address:
PO Box 619100, Dallas, United States
cash2make
cash2make Dec. 23 at 3:09 AM
$KMB let’s see 90 already
0 · Reply
Broview
Broview Dec. 23 at 1:05 AM
$KMB humiliatingly undervalued ? All in
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 8:37 PM
$KMB only thing that can save this is a new ceo. One thar didn't think it was a good idea to buy kvue
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 7:54 PM
$KMB literally every day is red. I don't mean some days, i mean everyday
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 7:14 PM
$KMB now that 100 is broken, it's in freefall.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 7:10 PM
$KMB so easy to short.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 6:45 PM
$KMB wrecked worse every single day.
1 · Reply
Pilot_Trader
Pilot_Trader Dec. 22 at 6:06 PM
$KMB sinus virus going around, Kleenex flying off the shelve, blue chip company with great revenue, below 5 year low, nice DIV, what’s not to love? Loading up!
1 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:53 PM
Is $KMB quietly building a competitive edge into 2026? 👀 Kimberly-Clark says its Powering Care strategy is driving volume-plus-mix growth, stronger innovation cycles, and clear margin ambitions as it heads into 2026 — a combo investors don’t ignore. Discover how this strategy could shape KMB’s path forward 👉 https://www.zacks.com/stock/news/2807578/is-kmbs-powering-care-strategy-building-a-competitive-edge-into-2026?cid=sm-stocktwits-2-2807578-teaser-25859&ADID=SYND_STOCKTWITS_TWEET_2_2807578_TEASER_25859
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 5:22 PM
$KMB once 100 doesn't hold, it's going to 90 soon.
0 · Reply
Latest News on KMB
Kimberly-Clark to Announce Fourth Quarter and Full Year 2025 Results on January 27, 2026

Dec 12, 2025, 7:10 AM EST - 10 days ago

Kimberly-Clark to Announce Fourth Quarter and Full Year 2025 Results on January 27, 2026

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

Dec 9, 2025, 10:15 AM EST - 13 days ago

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

AES AMCR ARE CAG CPB D DOC

Kimberly-Clark Corporation (KMB) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

Dec 3, 2025, 2:33 PM EST - 19 days ago

Kimberly-Clark Corporation (KMB) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 23 days ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR

Kimberly-Clark: An Undervalued Dividend Aristocrat For Income-Seeking Investors

Nov 24, 2025, 9:30 AM EST - 4 weeks ago

Kimberly-Clark: An Undervalued Dividend Aristocrat For Income-Seeking Investors

Kimberly-Clark To Webcast Its Presentation At Morgan Stanley's Global Consumer & Retail Conference

Nov 21, 2025, 4:10 PM EST - 4 weeks ago

Kimberly-Clark To Webcast Its Presentation At Morgan Stanley's Global Consumer & Retail Conference

Kimberly-Clark Declares Quarterly Dividend

Nov 20, 2025, 4:10 PM EST - 4 weeks ago

Kimberly-Clark Declares Quarterly Dividend

Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway

Nov 13, 2025, 1:51 PM EST - 5 weeks ago

Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway

TMO WAB

Jim Cramer calls the bottom in P&G and Kimberly-Clark stock

Nov 12, 2025, 6:06 AM EST - 5 weeks ago

Jim Cramer calls the bottom in P&G and Kimberly-Clark stock

PG

You've come to expect pain from stocks like Kimberly Clark, says Jim Cramer

Nov 11, 2025, 7:58 PM EST - 5 weeks ago

You've come to expect pain from stocks like Kimberly Clark, says Jim Cramer

I'm Buying Dividend Aristocrats At Bargain Basement Prices

Nov 10, 2025, 8:00 AM EST - 6 weeks ago

I'm Buying Dividend Aristocrats At Bargain Basement Prices

PEP

A Look at Earnings for Two Stocks

Nov 9, 2025, 8:33 AM EST - 6 weeks ago

A Look at Earnings for Two Stocks

HTGC

Watch These Stocks Falling 10% Or More

Nov 4, 2025, 4:58 PM EST - 6 weeks ago

Watch These Stocks Falling 10% Or More

AJG ARE BAX BRO CAVA CMG DECK

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

Nov 4, 2025, 2:26 PM EST - 6 weeks ago

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

KVUE IYK VDC XLP

3 Dividend Stocks for November 2025

Nov 4, 2025, 11:40 AM EST - 6 weeks ago

3 Dividend Stocks for November 2025

DEO GSK

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

Nov 3, 2025, 10:00 PM EST - 7 weeks ago

The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker

KVUE

Kimberly-Clark CEO Mike Hsu goes one-on-one with Jim Cramer

Nov 3, 2025, 8:05 PM EST - 7 weeks ago

Kimberly-Clark CEO Mike Hsu goes one-on-one with Jim Cramer

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

Nov 3, 2025, 7:11 PM EST - 7 weeks ago

Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

KVUE

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Nov 3, 2025, 6:40 PM EST - 7 weeks ago

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

KVUE

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

Nov 3, 2025, 5:20 PM EST - 7 weeks ago

Kenvue's legal risks loom over planned acquisition by Kimberly-Clark

KVUE

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

Nov 3, 2025, 5:15 PM EST - 7 weeks ago

S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue

AMZN KVUE

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

Nov 3, 2025, 4:58 PM EST - 7 weeks ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

KVUE

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

Nov 3, 2025, 4:39 PM EST - 7 weeks ago

Kimberly-Clark's $50 billion leap into health and beauty tests investor faith

KVUE

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

Nov 3, 2025, 4:01 PM EST - 7 weeks ago

KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

KVUE

Kimberly-Clark Corporation (KMB) M&A Call Transcript

Nov 3, 2025, 3:56 PM EST - 7 weeks ago

Kimberly-Clark Corporation (KMB) M&A Call Transcript

Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity

Nov 3, 2025, 3:56 PM EST - 7 weeks ago

Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity

Explainer: Is Tylenol safe to take during pregnancy?

Nov 3, 2025, 3:29 PM EST - 7 weeks ago

Explainer: Is Tylenol safe to take during pregnancy?

KVUE

Top Stock Movers Now: Amazon, Kenvue, Kimberly-Clark, Beyond Meat, and More

Nov 3, 2025, 12:55 PM EST - 7 weeks ago

Top Stock Movers Now: Amazon, Kenvue, Kimberly-Clark, Beyond Meat, and More

AMZN

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

Nov 3, 2025, 12:37 PM EST - 7 weeks ago

Kenvue deal could double Kimberly-Clark stock's multiple: find out more

KVUE

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Nov 3, 2025, 12:01 PM EST - 7 weeks ago

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

KVUE

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Nov 3, 2025, 11:40 AM EST - 7 weeks ago

Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

KVUE

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

Nov 3, 2025, 11:18 AM EST - 7 weeks ago

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

KVUE

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

Nov 3, 2025, 10:44 AM EST - 7 weeks ago

Kimberly-Clark buys Tylenol maker Kenvue in a cash and stock deal for $48.7 billion

KVUE

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

Nov 3, 2025, 10:33 AM EST - 7 weeks ago

Activist Investors in Kenvue Faced Big Losses. Kimberly-Clark Saved the Day.

KVUE

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

Nov 3, 2025, 9:57 AM EST - 7 weeks ago

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

KVUE

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Nov 3, 2025, 9:16 AM EST - 7 weeks ago

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

KVUE

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

Nov 3, 2025, 9:15 AM EST - 7 weeks ago

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

KVUE

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

Nov 3, 2025, 8:40 AM EST - 7 weeks ago

Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal

KVUE

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

Nov 3, 2025, 8:27 AM EST - 7 weeks ago

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

KVUE

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

Nov 3, 2025, 8:24 AM EST - 7 weeks ago

Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal

KVUE

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Nov 3, 2025, 8:14 AM EST - 7 weeks ago

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VERX

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

Nov 3, 2025, 7:49 AM EST - 7 weeks ago

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

KVUE

Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion

Nov 3, 2025, 6:50 AM EST - 7 weeks ago

Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion

KVUE

Kimberly-Clark to Buy Tylenol Maker Kenvue

Nov 3, 2025, 6:44 AM EST - 7 weeks ago

Kimberly-Clark to Buy Tylenol Maker Kenvue

KVUE

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

Nov 3, 2025, 6:36 AM EST - 7 weeks ago

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

KVUE

Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader

Nov 3, 2025, 6:30 AM EST - 7 weeks ago

Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader

KVUE

Kimberly-Clark Corporation (KMB) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 10:26 AM EDT - 7 weeks ago

Kimberly-Clark Corporation (KMB) Q3 2025 Earnings Call Transcript

Kimberly-Clark Profit Falls, Organic Sales Rise

Oct 30, 2025, 6:39 AM EDT - 7 weeks ago

Kimberly-Clark Profit Falls, Organic Sales Rise

Kimberly-Clark beats quarterly sales estimates as demand holds for household staples

Oct 30, 2025, 6:36 AM EDT - 7 weeks ago

Kimberly-Clark beats quarterly sales estimates as demand holds for household staples

cash2make
cash2make Dec. 23 at 3:09 AM
$KMB let’s see 90 already
0 · Reply
Broview
Broview Dec. 23 at 1:05 AM
$KMB humiliatingly undervalued ? All in
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 8:37 PM
$KMB only thing that can save this is a new ceo. One thar didn't think it was a good idea to buy kvue
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 7:54 PM
$KMB literally every day is red. I don't mean some days, i mean everyday
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 7:14 PM
$KMB now that 100 is broken, it's in freefall.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 7:10 PM
$KMB so easy to short.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 6:45 PM
$KMB wrecked worse every single day.
1 · Reply
Pilot_Trader
Pilot_Trader Dec. 22 at 6:06 PM
$KMB sinus virus going around, Kleenex flying off the shelve, blue chip company with great revenue, below 5 year low, nice DIV, what’s not to love? Loading up!
1 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:53 PM
Is $KMB quietly building a competitive edge into 2026? 👀 Kimberly-Clark says its Powering Care strategy is driving volume-plus-mix growth, stronger innovation cycles, and clear margin ambitions as it heads into 2026 — a combo investors don’t ignore. Discover how this strategy could shape KMB’s path forward 👉 https://www.zacks.com/stock/news/2807578/is-kmbs-powering-care-strategy-building-a-competitive-edge-into-2026?cid=sm-stocktwits-2-2807578-teaser-25859&ADID=SYND_STOCKTWITS_TWEET_2_2807578_TEASER_25859
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 5:22 PM
$KMB once 100 doesn't hold, it's going to 90 soon.
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 4:53 PM
$KMB's Powering Care strategy is already reshaping its competitive position — but is it enough to drive a comeback? 💪 Despite a 22.6% drop in the past six months, KMB has a Value Score of D, and its margin goals aim to strengthen its position for 2026 and beyond. However, the stock's forward P/E of 14.61 still lags behind the industry average. Is KMB's strategy a long-term win? Full analysis here 👉 https://www.zacks.com/stock/news/2807578/is-kmbs-powering-care-strategy-building-a-competitive-edge-into-2026?cid=sm-stocktwits-2-2807578-body-25861&ADID=SYND_STOCKTWITS_TWEET_2_2807578_BODY_25861
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 4:12 PM
$KMB clearly domebody big really wants this a lot lower.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 3:52 PM
$KMB every tiny pop gets wrecked
0 · Reply
NeverCapProfit
NeverCapProfit Dec. 22 at 3:07 PM
$KMB is not making much sense
0 · Reply
AbraKrak
AbraKrak Dec. 22 at 3:05 PM
$KMB Bought at 100. Looks undervalued, mostly influenced by negative sentiment over tylenol. $KVUE
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 3:00 PM
$KMB no bottom ever.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 2:52 PM
$KMB going a lot lower here
0 · Reply
TaylorTwits
TaylorTwits Dec. 22 at 2:46 PM
$KMB not our buy signal yet Its closer
1 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 2:46 PM
$KMB i tried telling everybody it was going under 100. Nobody believed me. But it was pretty obvious.
0 · Reply
fishinNbanjo
fishinNbanjo Dec. 22 at 2:39 PM
$KMB red always. Literally never goes up
0 · Reply
NeverCapProfit
NeverCapProfit Dec. 22 at 2:28 PM
$KMB another red today ?
0 · Reply
flbulltrader
flbulltrader Dec. 22 at 12:47 PM
$KMB started a new position!
0 · Reply